Potentially effective drugs for the treatment of COVID-19 or MIS-C in children: a systematic review

Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children

(2021) Naïm Ouldali et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Clinical efficacy and safety of remdesivir in patients with COVID-19: a systematic review and network meta-analysis of randomized controlled trials

(2021) Chih-Cheng Lai et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Compassionate Use of Remdesivir in Children With Severe COVID-19

(2021) David L. Goldman et al.   PEDIATRICS

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

(2021) Matthew J Page et al.   BMJ-British Medical Journal

Treatment of Multisystem Inflammatory Syndrome in Children

(2021) Andrew J. McArdle et al.   NEW ENGLAND JOURNAL OF MEDICINE

Immunotherapy for MIS-C — IVIG, Glucocorticoids, and Biologics

(2021) Roberta L. DeBiasi   NEW ENGLAND JOURNAL OF MEDICINE

Multisystem Inflammatory Syndrome in Children — Initial Therapy and Outcomes

(2021) Mary Beth F. Son et al.   NEW ENGLAND JOURNAL OF MEDICINE

Recent Experience

(2021) Vladislav Vukomanovic et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

FDA approves first peanut allergy drug

(2020) Asher Mullard   NATURE REVIEWS DRUG DISCOVERY

Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts’ consensus statement

(2020) Kunling Shen et al.   World Journal of Pediatrics

Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center’s observational study

(2020) Dan Sun et al.   World Journal of Pediatrics

Clinical characteristics of children with COVID-19: a rapid review and meta-analysis

(2020) Zijun Wang et al.   Annals of Translational Medicine

Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study

(2020) Luca Carsana et al.   LANCET INFECTIOUS DISEASES

Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report

(2020)   NEW ENGLAND JOURNAL OF MEDICINE

Clinical Characteristics of Children With COVID-19: A Meta-Analysis

(2020) Yudan Ding et al.   Frontiers in Pediatrics

Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19

(2020) et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process

(2020) Rachel Harwood et al.   Lancet Child & Adolescent Health

Addition of Corticosteroids to Immunoglobulins Is Associated With Recovery of Cardiac Function in Multi-Inflammatory Syndrome in Children

(2020) Zahra Belhadjer et al.   CIRCULATION

American College of Rheumatology Clinical Guidance for Pediatric Patients with Multisystem Inflammatory Syndrome in Children (MIS‐C) Associated with SARS‐CoV‐2 and Hyperinflammation in COVID‐19. Version 2.

(2020) Lauren A. Henderson et al.   Arthritis & Rheumatology

A principal component analysis is conducted for a case series quality appraisal checklist

(2016) Bing Guo et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions

(2016) Jonathan AC Sterne et al.   BMJ-British Medical Journal

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions

(2016) Jonathan AC Sterne et al.   BMJ-British Medical Journal

GRADE guidelines: 9. Rating up the quality of evidence

(2011) Gordon H. Guyatt et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

GRADE guidelines: 7. Rating the quality of evidence—inconsistency

(2011) Gordon H. Guyatt et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

GRADE guidelines: 8. Rating the quality of evidence—indirectness

(2011) Gordon H. Guyatt et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

GRADE guidelines: 5. Rating the quality of evidence—publication bias

(2011) Gordon H. Guyatt et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables

(2011) Gordon Guyatt et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

GRADE guidelines: 4. Rating the quality of evidence—study limitations (risk of bias)

(2011) Gordon H. Guyatt et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

GRADE guidelines 6. Rating the quality of evidence—imprecision

(2011) Gordon H. Guyatt et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY